» Articles » PMID: 33060744

Gender- and Age-related Differences in Homocysteine Concentration: a Cross-sectional Study of the General Population of China

Overview
Journal Sci Rep
Specialty Science
Date 2020 Oct 16
PMID 33060744
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The primary goals of this study were to evaluate the gender- and age-related differences in homocysteine concentration in the general population of China and possible influencing factors. A total of 7872 subjects, divided into male and female groups, participated in this retrospective study. The average homocysteine level, prevalence of hyperhomocysteinemia, and independent factors affecting homocysteine concentration were analyzed. The homocysteine level was significantly higher in males than in females in each age range (aged 20-30, aged 30-40, aged 40-50, aged 50-60, aged 60-80, aged over 80) (P < 0.0001), and the trend did not abate with age. The homocysteine concentration first decreased and then increased, being lowest at 30-50 years of age and significantly increased after 50 years of age. Factors associated with homocysteine concentration in males were smoking status (current smokers versus ex-smokers: β: 0.112), estimated glomerular filtration rate (β =  - 0.192), blood urea nitrogen (β =  - 0.14), diastolic blood pressure (β =  - 0.113), free triiodothyronine (β =  - 0.091), serum potassium (β =  - 0.107) and cystatin C (β = 0.173). In females, independent factors associated with homocysteine concentration were cystatin C (β = 0.319), albumin (β = 0.227), free thyroxine (β = 0.179), age (β = 0.148), free triiodothyronine (β =  - 0.217) and serum potassium (β =  - 0.153). The homocysteine level was significantly higher in males than in females and increased markedly after 50 years of age in both groups. The independent factors associated with increased homocysteine concentration differed between males and females.

Citing Articles

Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.

Janus A, Dumas D, Le Douce J, Marie S, Pasculli G, Bambury P Neurol Ther. 2024; 14(1):357-377.

PMID: 39708220 PMC: 11762061. DOI: 10.1007/s40120-024-00691-w.


Hyperhomocysteinemia and its Association with Cognitive Functioning-A Cross-sectional Study from an Ageing Cohort in South India.

G S, Ghosh A, Menon A, Roy D, S M, Issac T Indian J Psychol Med. 2024; :02537176241285127.

PMID: 39564338 PMC: 11572696. DOI: 10.1177/02537176241285127.


Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases.

Lin W, Yu D, Xiong L, Zebarth J, Wang R, Fischer C Alzheimers Dement. 2024; 21(1):e14376.

PMID: 39559926 PMC: 11775453. DOI: 10.1002/alz.14376.


Association between homocysteine levels and mortality in CVD: a cohort study based on NHANES database.

Liu D, Fang C, Wang J, Tian Y, Zou T BMC Cardiovasc Disord. 2024; 24(1):652.

PMID: 39548360 PMC: 11568605. DOI: 10.1186/s12872-024-04317-9.


Comparison of homocysteine, vitamin B12 and folic acid between rural and urban ageing Indians and its association with mild cognitive impairment and cardiovascular risk factors: a cross-sectional analysis.

Mallikarjun D, Malo P, Mensegere A, Partha A, Sundarakumar J, Issac T Brain Commun. 2024; 6(5):fcae343.

PMID: 39411243 PMC: 11474239. DOI: 10.1093/braincomms/fcae343.


References
1.
Fonseca V, Guba S, Fink L . Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev. 1999; 20(5):738-59. DOI: 10.1210/edrv.20.5.0381. View

2.
. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002; 288(16):2015-22. DOI: 10.1001/jama.288.16.2015. View

3.
Esse R, Barroso M, Tavares de Almeida I, Castro R . The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art. Int J Mol Sci. 2019; 20(4). PMC: 6412520. DOI: 10.3390/ijms20040867. View

4.
Falasca K, Di Nicola M, Di Martino G, Ucciferri C, Vignale F, Occhionero A . The impact of homocysteine, B, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects. BMC Infect Dis. 2019; 19(1):105. PMC: 6360746. DOI: 10.1186/s12879-019-3742-8. View

5.
Stampfer M, MALINOW M, Willett W, Newcomer L, Upson B, Ullmann D . A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992; 268(7):877-81. View